Double-Check Dosing of Direct Oral Anticoagulants (DOACs) in Certain Patients

July 2017

How should you dose direct oral anticoagulants (DOACs) such as Pradaxa (dabigatran) in obese, low body weight, or dialysis patients?

There's not much evidence to guide DOAC dosing in these patients...so stick with warfarin when possible.

But follow these general guidelines if a DOAC is preferred.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote